Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis
Theranostics · 2026
DOI: 10.7150/thno.127118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Samar A Antar und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fralin Biomedical Research Institute at Virginia Tech Carilion, Virginia, USA. Hauptthemen laut MEDLINE: Inhibitor of Differentiation Protein 1, Inhibitor of Differentiation Proteins, Fibroblasts, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fralin Biomedical Research Institute at Virginia Tech Carilion, Virginia, USA.
- Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
- Icahn School of Medicine at Mount Sinai, New York, USA.
- Arthritis and Autoimmune Diseases Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
- Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
- Department of Zoology, Faculty of Science, Assiut University, Assiut, Egypt.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Antar, S. A., Mensah, E., Dahlka, J., Renton, M. C., Raslan, A. A., Aziz, M., Halouani, A., Imani, S., Parashar, A., Johnstone, S. R., Benezra, R., Fraidenraich, D., Ligresti, G., & Sassi, Y. (2026). Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis. Theranostics. https://doi.org/10.7150/thno.127118
Vancouver
Antar SA, Mensah E, Dahlka J, Renton MC, Raslan AA, Aziz M, et al. Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis. Theranostics. 2026. doi:10.7150/thno.127118
BibTeX
@article{Antar2026,
author = {Antar, Samar A and Mensah, Eric and Dahlka, Jacob and Renton, Mark C and Raslan, Ahmed A and Aziz, Michael and Halouani, Aymen and Imani, Seun and Parashar, Aanandi and Johnstone, Scott R and Benezra, Robert and Fraidenraich, Diego and Ligresti, Giovanni and Sassi, Yassine},
title = {Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.127118}
}
EUVIMED